Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.5.1.18 (
glutathione S-transferase
)
22,582
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The present studies were undertaken to elucidate the mechanism of induction of
glutathione S-transferase
(
GST
) in mouse liver by myristicin, an active constituent of parsley leaf. A/J albino mice, given 5 to 50 mg doses of myristicin, showed 4- to 14-fold increase in liver
GST
specific activity over the control.
GST
purified from equal amounts of control and myristicin-treated livers indicated a marked increase in the
GST
activity. A relatively higher increase in
GST
activity towards 2,4-dichloronitrobenzene and a profound increase in the levels of
GST
mu on Western blot analysis of the myristicin-treated mouse liver suggest a preferential induction of
GST
mu. Results of the study also indicate that out of the two mu class
GST
subunits (Mr. 26,500 and Mr. 25,000) expressed in liver only one (Mr. 26,500) is significantly elevated.
Myristicin
treatment caused a slight change in the
GST
pi levels while the levels of
GST
alpha showed a modest increase. These results suggest that myristicin could be an effective chemopreventive agent, particularly for carcinogens that are detoxified by the mu class
GST
.
...
PMID:Preferential overexpression of a class MU glutathione S-transferase subunit in mouse liver by myristicin. 924 41